THE SOCIAL GENETIC ASPECTS OF HIGHER PREVALENCE AND PREVENTION OF BASAL CELL CARCINOMA

  • Authors: Khabriev R.U.1,2, Sadykova R.N.1,2,3, Mingazova E.N.1,2,3,4, Bespyatykh J.A.1,2,5
  • Affiliations:
    1. N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia
    3. The Medical Biologic University of Innovations and Continuing Education of The Federal State Budget Institution “The A. I. Burnazyan State Scientific Center of The Russian Federation — Federal Medical Biophysical Center” of the Federal Medical Biological Agency of Russia, 123098, Moscow, Russia
    4. The Federal State Budget Institution of Higher Education “The Kazan State Medical University” of Minzdrav of Russia, 420012, Kazan, Russia
    5. The Federal State Budget Institution “The Academician Yu. M. Lopuhin Federal Scientific Clinical Center of Physicochemical Medicine” of the Federal Medical Biological Agency of Russia, 119435, Moscow, Russia
  • Issue: Vol 31, No 4 (2023)
  • Pages: 527-534
  • Section: Articles
  • URL: https://journal-nriph.ru/journal/article/view/1855
  • DOI: https://doi.org/10.32687/0869-866X-2023-31-4-527-534
  • Cite item

Abstract


The article analyzes modern scientific publications that consider increasing of prevalence of basal cell carcinoma that ranks high among cases of skin cancer in all racial ethnic populations of the world, comparable with increasing prevalence of cancer of esophagus, ovaries and thyroid gland. In most countries of the world, including countries with high income level, reliable epidemiological data and national registers of basal cell carcinoma are absent. The multi-factorial etiology of basal cell carcinoma that includes environmental and genetic factors combined with social economic variables, is associated with prevalence of particular sub-types of basal cell carcinoma depending on gender, age, racial ethnic and genetic factors, as well as concomitant diseases, previous treatment and other indicators.

About the authors

R. U. Khabriev

N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia;

R. N. Sadykova

N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia; ;The Medical Biologic University of Innovations and Continuing Education of The Federal State Budget Institution “The A. I. Burnazyan State Scientific Center of The Russian Federation — Federal Medical Biophysical Center” of the Federal Medical Biological Agency of Russia, 123098, Moscow, Russia;

E. N. Mingazova

N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia; ;The Medical Biologic University of Innovations and Continuing Education of The Federal State Budget Institution “The A. I. Burnazyan State Scientific Center of The Russian Federation — Federal Medical Biophysical Center” of the Federal Medical Biological Agency of Russia, 123098, Moscow, Russia; ;The Federal State Budget Institution of Higher Education “The Kazan State Medical University” of Minzdrav of Russia, 420012, Kazan, Russia;

J. A. Bespyatykh

N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia; ;The Federal State Budget Institution “The Academician Yu. M. Lopuhin Federal Scientific Clinical Center of Physicochemical Medicine” of the Federal Medical Biological Agency of Russia, 119435, Moscow, Russia

References

  1. McDaniel B., Badri T., Steele R. B. Basal Cell Carcinoma. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Sep 19.
  2. Xie D., Chen X., Wu H., Ning D., Cao X., Wan C. Prediction of Diagnostic Gene Biomarkers Associated with Immune Infiltration for Basal Cell Carcinoma. Clin. Cosmet. Investig. Dermatol. 2022;15:2657—73. doi: 10.2147/CCID.S390770
  3. Sgouros D., Rigopoulos D., Panayiotides I. Novel Insights for Patients with Multiple Basal Cell Carcinomas and Tumors at HighRisk for Recurrence: Risk Factors, Clinical Morphology, and Dermatoscopy. Cancers (Basel). 2021;13(13). doi: 10.3390/cancers13133208
  4. Ciążyńska M., Narbutt J., Woźniacka A., Lesiak A. Trends in basal cell carcinoma incidence rates: a 16-year retrospective study of a population in central Poland. Postepy Dermatol. Alergol. 2018;35(1):47—52. doi: 10.5114/ada.2018.73164
  5. Ramelyte E., Nägeli M. C., Hunger R. Swiss Recommendations for Cutaneous Basal Cell Carcinoma. Dermatology. 2023;239(1):122—31. doi: 10.1159/000526478
  6. Yao Y., Li T., Huang Y., Cheng H. A Case of Giant Basal Cell Carcinoma of the Ear Complicated by Primary Cutaneous Aspergillosis. Clin. Cosmet. Investig. Dermatol. 2022;15:2841—4. doi: 10.2147/CCID.S392871
  7. Kim M., Kim J. W., Shin J. W., Na J. I., Huh C. H. Basal cell carcinoma of the scalp shows distinct features from the face in Asians. Sci. Rep. 2022;12(1). doi: 10.1038/s41598-022-14533-y
  8. Kibriya M. G., Jasmine F., Munoz A. Interaction of Arsenic Exposure and Transcriptomic Profile in Basal Cell Carcinoma. Cancers (Basel). 2022;14(22). doi: 10.3390/cancers14225598
  9. Teng Y., Yu Y., Li S., Huang Y., Xu D., Tao X., Fan Y. Ultraviolet Radiation and Basal Cell Carcinoma: An Environmental Perspective. Front. Public Health. 2021;9. doi: 10.3389/fpubh.2021.666528
  10. Peris K., Fargnoli M. C., Garbe C. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur. J. Cancer. 2019;118:10—34. doi: 10.1016/j.ejca.2019.06.003
  11. Bichakjian C. K., Olencki T., Aasi S. Z. Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 2016;14(5):574—97. doi: 10.6004/jnccn.2016.0065
  12. Badash I., Shauly O., Lui C. G., Gould D. J., Patel K. M. Nonmelanoma Facial Skin Cancer: A Review of Diagnostic Strategies, Surgical Treatment, and Reconstructive Techniques. Clin. Med. Insights Ear Nose Throat. 2019;12:1179550619865278. doi: 10.1177/1179550619865278
  13. Ramdas K., van Lee C., Beck S. Differences in Rate of Complete Excision of Basal Cell Carcinoma by Dermatologists, Plastic Surgeons and General Practitioners: A Large Cross-Sectional Study. Dermatology. 2018;234(3—4):86—91. doi: 10.1159/000490344
  14. Peters M., Smith J. D., Kovatch K. J., McLean S., Durham A. B., Basura G. Treatment and Outcomes for Cutaneous Periauricular Basal Cell Carcinoma: A 16-Year Institutional Experience. OTO Open. 2020;4(4). doi: 10.1177/2473974X20964735
  15. Keah S. H., Ng S. C. Basal Cell Carcinoma Surgery in general practice: Is there a role for the local General Practitioner? Malays Fam. Physician. 2020;15(3):10—21.
  16. Di Brizzi E. V., Argenziano G., Brancaccio G. The current clinical approach to difficult-to-treat basal cell carcinomas. Expert. Rev. Anticancer Ther. 2023;23(1):43—56. doi: 10.1080/14737140.2023.2161517
  17. Kavoussi H., Ebrahimi A., Rezaei M. Comparison of Demographic and Clinicopathological Characteristics of Basal Cell Carcinoma on the Nose and Other Sites of the Face: A Cross-Sectional Study. Iran J. Otorhinolaryngol. 2021;33(118):257—62. doi: 10.22038/ijorl.2021.47720.2575
  18. Adachi K., Yoshida Y., Noma H., Goto H., Yamamoto O. Characteristics of multiple basal cell carcinomas: The first study on Japanese patients. J. Dermatol. 2018;45(10):1187—90. doi: 10.1111/1346-8138.14576
  19. El-Khalawany M., Hassab-El-Naby H. M. M., Mousa A. M. Epidemiological and clinicopathological analysis of basal cell carcinoma in Egyptian population: a 5-year retrospective multicenter study. J. Cancer Res. Clin. Oncol. 2022. doi: 10.1007/s00432-022-04207-7
  20. Ozkanli S., Soylemez T., Keskin H. A Five-Year Retrospective Analysis of Basal Cell Carcinoma: A Monocentric Study. Medeni Med. J. 2020;35(3):219—25. doi: 10.5222/MMJ.2020.923324
  21. Lukowiak T. M., Aizman L., Perz A. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States. JAMA Dermatol. 2020;156(11):1192—8. doi: 10.1001/jamadermatol.2020.2571
  22. Halip I. A., Vâţă D., Statescu L. Assessment of Basal Cell Carcinoma Using Dermoscopy and High Frequency Ultrasound Examination. Diagnostics (Basel). 2022;12(3). doi: 10.3390/diagnostics12030735
  23. Laverde-Saad A., Simard A., Nassim D., Jfri A. Performance of Ultrasound for Identifying Morphological Characteristics and Thickness of Cutaneous Basal Cell Carcinoma: A Systematic Review. Dermatology. 2022;238(4):692—710. doi: 10.1159/000520751
  24. Gallo J. C., Schneider J. W., de Wet J. A Profile and Three-Year Follow-Up of Patients with Basal Cell Carcinoma in the Western Cape, South Africa. J. Skin Cancer. 2022. doi: 10.1155/2022/8443867
  25. Jain C., Garg N., Singh S., Chattopadhyay S. Basal cell carcinoma-clinico-pathological study in Eastern India in correlation with different risk factors. Indian J. Pathol. Microbiol. 2022;65(4):869—72. doi: 10.4103/ijpm.ijpm
  26. Chlebicka I., Stefaniak A., Matusiak Ł., Szepietowski J. C. Basal cell carcinoma: what new can be learned about the most common human cancer? A cross-sectional prospective study of 180 cases in a single centre. Postepy Dermatol. Alergol. 2021;38(6):1086—91. doi: 10.5114/ada.2021.106026
  27. Płaszczyńska A., Skibiński R., Sławińska M. Clinical and histopathological characteristics of primary and recurrent basal cell carcinoma: a retrospective study of the patients from a tertiary clinical centre in the northern Poland. Postepy Dermatol. Alergol. 2022;39(1):126—31. doi: 10.5114/ada.2022.113806
  28. Kiely J. R., Patel A. J. K. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin. J. Plast. Reconstr. Aesthet. Surg. 2019;72(11):1805—12. doi: 10.1016/j.bjps.2019.06.002
  29. Savoia P., Veronese F., Camillo L. Multiple Basal Cell Carcinomas in Immunocompetent Patients. Cancers (Basel). 2022;14(13). doi: 10.3390/cancers14133211
  30. Lin Z., Qidwai U., Igali L., Hemmant B. A multicentre review of the histology of 1012 periocular basal cell carcinomas. Eur. J. Ophthalmol. 2021;31(5):2699—704. doi: 10.1177/1120672120957597
  31. Dethmers A., Löw U., Langenbucher A. Rezidivrisiko von periokulären Basalzellkarzinomen nach histologisch kontrollierter Exzision [Recurrence risk of periocular basal cell carcinoma after histologically controlled excision]. Ophthalmologie. 2022. doi: 10.1007/s00347-022-01719-y
  32. Thakurani S., Gupta S., Mohammad A., Escandón J. M. Facial Basal Cell Carcinoma: A Study of Causative Factors and Site-based Algorithm for Surgical Reconstruction. J. Cutan. Aesthet. Surg. 2022;15(3):275—83. doi: 10.4103/JCAS.JCAS_113_21
  33. Oh C. M., Cho H., Won Y. J. Nationwide Trends in the Incidence of Melanoma and Non-melanoma Skin Cancers from 1999 to 2014 in South Korea. Cancer Res. Treat. 2018;50(3):729—37. doi: 10.4143/crt.2017.166
  34. Tiyawatanaroj A., Sudtikoonaseth P., Chayangsu O. Basal cell carcinoma trends in Thailand: A 10-year retrospective study of demographic, clinical and histopathological features. Dermatol. Rep. 2021;14(1). doi: 10.4081/dr.2022.9413

Statistics

Views

Abstract - 0

PDF (Russian) - 0

Cited-By


PlumX

Dimensions


Copyright (c) 2023 АО "Шико"

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mailing Address

Address: 105064, Vorontsovo Pole, 12, Moscow

Email: ttcheglova@gmail.com

Phone: +7 903 671-67-12

Principal Contact

Tatyana Sheglova
Head of the editorial office
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Phone: +7 903 671-67-12
Email: redactor@journal-nriph.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies